HUNTINGTON BANCSHARES ($HBAN) posted quarterly earnings results on Friday, October 17th. The company reported earnings of $0.40 per share, beating estimates of $0.38 by $0.02. The company also reported revenue of $2,151,000,000, beating estimates of $2,079,852,736 by $71,147,264.
You can see Quiver Quantitative's $HBAN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HUNTINGTON BANCSHARES Insider Trading Activity
HUNTINGTON BANCSHARES insiders have traded $HBAN stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $HBAN stock by insiders over the last 6 months:
- BRANTLEY J STANDRIDGE (Senior Exec. V.P.) sold 70,417 shares for an estimated $963,938
- MARCY C HINGST (SEVP and General Counsel) has made 0 purchases and 2 sales selling 54,800 shares for an estimated $956,123.
- ZACHARY JACOB WASSERMAN (CFO and Senior Exec. V.P.) sold 59,060 shares for an estimated $848,281
- HELGA HOUSTON (Senior Exec. V. P.) sold 42,344 shares for an estimated $623,401
- KENDALL A KOWALSKI (Chief Information Officer) has made 0 purchases and 2 sales selling 28,853 shares for an estimated $397,533.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HUNTINGTON BANCSHARES Hedge Fund Activity
We have seen 499 institutional investors add shares of HUNTINGTON BANCSHARES stock to their portfolio, and 424 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 12,517,180 shares (+9.6%) to their portfolio in Q2 2025, for an estimated $209,787,936
- CITADEL ADVISORS LLC removed 9,920,230 shares (-32.9%) from their portfolio in Q2 2025, for an estimated $166,263,054
- AMUNDI removed 7,015,407 shares (-31.9%) from their portfolio in Q2 2025, for an estimated $117,578,221
- PRICE T ROWE ASSOCIATES INC /MD/ removed 6,585,284 shares (-9.2%) from their portfolio in Q2 2025, for an estimated $110,369,359
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 5,811,120 shares (-66.6%) from their portfolio in Q2 2025, for an estimated $97,394,371
- VICTORY CAPITAL MANAGEMENT INC added 5,761,911 shares (+24.2%) to their portfolio in Q2 2025, for an estimated $96,569,628
- MILLENNIUM MANAGEMENT LLC removed 4,225,294 shares (-54.6%) from their portfolio in Q2 2025, for an estimated $70,815,927
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HUNTINGTON BANCSHARES Analyst Ratings
Wall Street analysts have issued reports on $HBAN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 09/12/2025
- Jefferies issued a "Buy" rating on 09/03/2025
- DA Davidson issued a "Buy" rating on 07/21/2025
- Wolfe Research issued a "Outperform" rating on 07/03/2025
- Citigroup issued a "Buy" rating on 07/02/2025
- RBC Capital issued a "Outperform" rating on 04/21/2025
- Raymond James issued a "Strong Buy" rating on 04/21/2025
To track analyst ratings and price targets for HUNTINGTON BANCSHARES, check out Quiver Quantitative's $HBAN forecast page.
HUNTINGTON BANCSHARES Price Targets
Multiple analysts have issued price targets for $HBAN recently. We have seen 9 analysts offer price targets for $HBAN in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Manan Gosalia from Morgan Stanley set a target price of $23.0 on 09/29/2025
- Brian Foran from Truist Securities set a target price of $20.0 on 09/12/2025
- David Chiaverini from Jefferies set a target price of $21.0 on 09/03/2025
- Peter Winter from DA Davidson set a target price of $20.0 on 07/21/2025
- David Long from Raymond James set a target price of $21.0 on 07/08/2025
- Keith Horowitz from Citigroup set a target price of $20.0 on 07/02/2025
- Karl Shepard from RBC Capital set a target price of $18.0 on 04/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
